Polymorphisms in the TNFA gene and the risk of inhibitor development in patients with hemophilia A.
about
Animal models of hemophiliaImportance of immune response genes in hemophilia AFVIII inhibitors: pathogenesis and avoidanceRecombinant factor VIII Fc (rFVIIIFc) fusion protein reduces immunogenicity and induces tolerance in hemophilia A miceAntidrug Antibodies: B Cell Immunity Against TherapyT-cell responses in two unrelated hemophilia A inhibitor subjects include an epitope at the factor VIII R593C missense site.HLA-DR-restricted T-cell responses to factor VIII epitopes in a mild haemophilia A family with missense substitution A2201P.Validity of assessing inhibitor development in haemophilia PUPs using registry data: the EUHASS project.Increased prevalence of inhibitors in Hispanic patients with severe haemophilia A enrolled in the Universal Data Collection database.The IL-10 polarized cytokine pattern in innate and adaptive immunity cells contribute to the development of FVIII inhibitors.A case-control study reveals immunoregulatory gene haplotypes that influence inhibitor risk in severe haemophilia A.Characterization of the anti-factor VIII immunoglobulin profile in patients with hemophilia A by use of a fluorescence-based immunoassay.Treatment of hemophilia: a review of current advances and ongoing issuesF8 haplotype and inhibitor risk: results from the Hemophilia Inhibitor Genetics Study (HIGS) Combined Cohort.The polygenic nature of inhibitors in hemophilia A: results from the Hemophilia Inhibitor Genetics Study (HIGS) Combined Cohort.International workshop on immune tolerance induction: consensus recommendations.Inhibitor development in haemophilia B: an orphan disease in need of attention.Inhibitor development.Genetic aspects and research development in haemostasis.Achievements, challenges and unmet needs for haemophilia patients with inhibitors: Report from a symposium in Paris, France on 20 November 2014.Development of inhibitory antibodies to therapeutic factor VIII in severe hemophilia A is associated with microsatellite polymorphisms in the HMOX1 promoter.Inhibitors of factor VIII in black patients with hemophiliaNovel drugs to treat hemophilia.Clinical advances in hemophilia management.Immune tolerance induction in haemophilia: evidence and the way forward.Do proteolytic antibodies complete the panoply of the autoimmune response in acquired haemophilia A?Inhibitors in childhood hemophilia A: genetic and treatment-related risk factors for development and eradication.Factor VIII inhibitors in hemophilia A: rationale and latest evidenceGenomics of bleeding disorders.Inhibitors in haemophilia: what have we learned from registries? A systematic review.Genetic risk factors for inhibitors in haemophilia A.Strategies for reducing inhibitor formation in severe haemophilia.Violating the theory of single gene-single disorder: inhibitor development in hemophiliaThe role of previously untreated patient studies in understanding the development of FVIII inhibitors.The Development of FVIII Inhibitors in Relation to IL10 Gene Polymorphism in Hemophilia A Egyptian Pediatric Patients.A Polymorphism in the IL-5 Gene is Associated with Inhibitor Development in Severe Hemophilia A PatientsNon-genetic risk factors in haemophilia A inhibitor management - the danger theory and the use of animal models.A large-scale computational study of inhibitor risk in non-severe haemophilia A.Anti-factor VIII antibodies in brothers with haemophilia A share similar characteristics.Prevention and prediction of inhibitor risk.
P2860
Q27012571-E5C8C918-7564-4337-AD17-6FC5DCBB2283Q27025467-701941AF-23DB-4B5D-8D0E-A6502828F46EQ27027224-B9235DF7-6D65-4693-9984-D1BC1C323E2AQ27321626-F831D3F7-6B25-4700-BB1A-84478BFBAC99Q28082303-BAE70D2E-C550-4FC5-9F02-40B96538ABF5Q30620098-57BF8FB4-55A2-4A85-9A00-186778906D71Q33910694-E2D92424-79F0-4C7C-B31D-FFEFA6AF2C59Q34063824-103AE456-F712-4BB7-90D7-6E80B815C80BQ34129239-B3E3863E-ECF8-497A-B4E6-935CDA1EC257Q35046770-70086D88-BDBD-44B1-B83E-395454868D4EQ35061778-E1D0A718-EAD7-4C0E-9652-1593115C0D32Q35248264-5DB2B4DC-3973-443B-93B6-1BF4F034A0E3Q35683781-AFD69753-3824-4485-BD82-A345A1C95C2BQ36463399-F2329700-5468-4E88-9FAD-ECBB0F23AF75Q36628311-A16B2CB1-1CBE-446C-A487-499777DD8DD1Q36861097-AFC02A6B-E734-4178-A854-16F56F2F599BQ36872038-0EAF56A1-50E1-452D-BD1E-BE4C4E59C734Q37176486-1272F614-D9B2-433D-9509-605B70A66255Q37176521-0A8B526B-91CD-4800-8C62-A102A84149DDQ37185097-3041CBEF-7845-43F7-9A4E-3D244A7BB2DFQ37212741-DABF2058-2F35-4362-B578-483576CA90CBQ37385316-C3A350F3-250E-4D3F-B979-CD84B3159330Q37775029-12AEC746-1E9D-426E-BCD6-C1189515DA54Q37900933-B978397B-461B-4273-8D6D-32411B0A25E9Q37903944-E61AAF3B-1C5F-4E82-B34A-216F051BB487Q37944291-CFBB932D-B320-455A-9E91-11F60D5A2CB0Q38056462-7795996C-8547-4102-BA3F-0A40BA82732AQ38101041-27446E03-F006-4FBC-81A0-489BEDE56D59Q38206853-80BA4F3C-B558-4C17-A90A-8340371B745FQ38244389-B443A21A-F051-4439-89A2-77F48656EC66Q38308196-C4B74656-69D2-4FD0-ABAC-F846976DE9C9Q38308222-60645484-87EA-4ACA-B690-3B2F50427B27Q38397087-7F14B02F-4A92-4129-98F3-5AF449B205C6Q38575475-591C4AEE-FF4D-4A74-9143-87C92CD06901Q38748723-563C6DD8-781A-4254-9173-D3C133016719Q38914615-5D825A75-F59D-48EA-83C1-613ED332F037Q38937408-05D4FD1D-6618-4467-B550-5BE06BE3FD76Q39125208-DE4AAE12-A482-4561-A26A-A9770F17D247Q39174749-73F1B2AC-94DE-45B7-859E-FC576520B8E4Q39596266-327887F4-396E-4E81-834E-38955859D017
P2860
Polymorphisms in the TNFA gene and the risk of inhibitor development in patients with hemophilia A.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Polymorphisms in the TNFA gene ...... in patients with hemophilia A.
@en
Polymorphisms in the TNFA gene ...... in patients with hemophilia A.
@nl
type
label
Polymorphisms in the TNFA gene ...... in patients with hemophilia A.
@en
Polymorphisms in the TNFA gene ...... in patients with hemophilia A.
@nl
prefLabel
Polymorphisms in the TNFA gene ...... in patients with hemophilia A.
@en
Polymorphisms in the TNFA gene ...... in patients with hemophilia A.
@nl
P2093
P921
P1433
P1476
Polymorphisms in the TNFA gene ...... in patients with hemophilia A.
@en
P2093
Ann-Kari Lefvert
Anna Pavlova
Erik Berntorp
Jan Astermark
Johannes Oldenburg
Joyce Carlson
Kaan Kavakli
P304
P356
10.1182/BLOOD-2006-05-024711
P407
P577
2006-08-22T00:00:00Z